{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:51:30Z","timestamp":1791888690657,"version":"4.3.4"},"reference-count":27,"publisher":"Japanese Pharmacological Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Folia Pharmacologica Japonica","Folia Pharmacol. Jpn."],"published-print":{"date-parts":[[2003]]},"DOI":"10.1254\/fpj.122.384","type":"journal-article","created":{"date-parts":[[2004,4,13]],"date-time":"2004-04-13T06:04:58Z","timestamp":1081836298000},"page":"384-390","source":"Crossref","is-referenced-by-count":1,"title":["Pathophysiological roles of the prostanoids in the cardiovascular system: Studies using mice deficient in prostanoid receptors"],"prefix":"10.1254","volume":"122","author":[{"given":"Akiyoshi","family":"HARA","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Asahikawa Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-ichi","family":"YUHKI","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Asahikawa Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"FUJINO","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Asahikawa Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuh","family":"NARUMIYA","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Kyoto University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"USHIKUBI","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Asahikawa Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"332","reference":[{"key":"1","unstructured":"1) Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev. 1994;46:205-229."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Ushikubi F, Hirata M, Narumiya S. Molecular biology of prostanoid receptors; an overview. J Lipid Mediat. 1995;12:343-359.","DOI":"10.1016\/0929-7855(95)00022-I"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors; structures, properties, and functions. Physiol Rev. 1999;79:1193-1226.","DOI":"10.1152\/physrev.1999.79.4.1193"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4) Coker SJ, Parratt JR, Ledingham IM, Zeitlin IJ. Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature. 1981;291:323-324.","DOI":"10.1038\/291323a0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Engels W, Van Bilsen M, De Groot MJ, et al. Ischemia and reperfusion induced formation of eicosanoids in isolated rat hearts. Am J Physiol. 1990;258:H1865-H1871.","DOI":"10.1152\/ajpheart.1990.258.6.H1865"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Bouchard JF, Lamontagne D. Mechanisms of protection afforded by cyclooxygenase inhibitors to endothelial function against ischemic injury in rat isolated hearts. J Cardiovasc Pharmacol. 1999;34:755-763.","DOI":"10.1097\/00005344-199911000-00019"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Lerner RW, Lopaschuk GD, Catena RC, Olley PM. [<sup>3<\/sup>H]Iloprost and prostaglandin E<sub>2<\/sub> compete for the same receptor site on cardiac sarcolemmal membranes. Biochim Biophys Acta. 1992;1105:189-192.","DOI":"10.1016\/0005-2736(92)90193-P"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Bowling N, Dube GP, Kurtz WL, et al. Characterization of thromboxane A<sub>2<\/sub>\/prostaglandin H<sub>2<\/sub> binding sites in guinea pig cardiac membrane preparations. J Mol Cell Cardiol. 1994;26:915-923.","DOI":"10.1006\/jmcc.1994.1109"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Jackson WF, Konig A, Dambacher T, Busse R. Prostacyclin-induced vasodilation in rabbit heart is mediated by ATP-sensitive potassium channels. Am J Physiol. 1993;264:H238-H243.","DOI":"10.1152\/ajpheart.1993.264.1.H238"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ushikubi F, Hirata M, Narumiya S. Platelet prostaglandin receptors. In: von Bruchhausen F, Walter U, editors. Hand Book of Experimental Pharmacology, Vol. 126 Platelets and Their Factors. Berlin: Springer-Verlag, 1997. p. 135-154.","DOI":"10.1007\/978-3-642-60639-7_7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Wise H, Jones RL. Characterization of prostanoid receptors on rat neutrophils. Br J Pharmacol. 1994;113:581-587.","DOI":"10.1111\/j.1476-5381.1994.tb17029.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Yanagisawa A, Smith JA, Brezinski ME, Lefer AM. Mechanism of antagonism of thromboxane receptors in vascular smooth muscle. Eur J Pharmacol. 1987;133:89-96.","DOI":"10.1016\/0014-2999(87)90209-3"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13) Xiao C-Y, Hara A, Yuhki K, et al. Roles of prostaglandin I<sub>2<\/sub> and thromboxane A<sub>2<\/sub> in cardiac ischemia-reperfusion injury; a study using mice lacking their respective receptors. Circulation. 2001;104:2210-2215.","DOI":"10.1161\/hc4301.098058"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Schr&ouml;r K, Addicks K, Darius H, Ohlendorf R, Rosen P. PGI<sub>2<\/sub> inhibits ischemia-induced platelet activation and prevents myocardial damage by inhibition of catecholamine release from adrenergic nerve terminals. Evidence for cAMP as common denominator. Thromb Res. 1981;21:175-180.","DOI":"10.1016\/0049-3848(84)90046-X"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Simpson PJ, Mitsos SE, Ventura A, et al. Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation. Am Heart J. 1987;113:129-137.","DOI":"10.1016\/0002-8703(87)90020-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17) Baker KM, Chernin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol. 1990;259:H324-H332.","DOI":"10.1152\/ajpheart.1990.259.2.H324"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18) Ito H. Endothelins and cardiac hypertrophy. Life Sci. 1997;61:585-593.","DOI":"10.1016\/S0024-3205(97)00105-7"},{"key":"18","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1161\/01.CIR.100.23.2359","volume":"100","year":"1999","unstructured":"19) Emanueli C, Maestri R, Corradi D, et al. Dilated and failing cardiomyopathy in bradykinin B<sub>2<\/sub> receptor knockout mice. Circulation. 1999;100:2359-2365.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20) Oliver PM, Fox JE, Kim R, et al. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA. 1997;94:14730-14735.","DOI":"10.1073\/pnas.94.26.14730"},{"key":"20","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.HYP.30.5.1047","volume":"30","year":"1997","unstructured":"21) Yu H, Gallagher AM, Garfin PM, Printz MP. Prostacyclin release by rat cardiac fibroblasts: inhibition of collagen expression. Hypertension. 1997;30:1047-1053.","journal-title":"Hypertension","ISSN":"https:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"21","doi-asserted-by":"crossref","unstructured":"25) Gardner NM, Broadley KJ. Analysis of the atypical characteristics of adenosine receptors mediating negative inotropic and chronotropic responses of guinea-pig isolated atria and papillary muscles. Br J Pharmacol. 1999;127:1619-1626.","DOI":"10.1038\/sj.bjp.0702719"},{"key":"22","doi-asserted-by":"crossref","unstructured":"26) Li Q, Zhang J, Pfaffendorf M, van Zwieten PA. Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atria. Br J Pharmacol. 1996;118:1653-1658.","DOI":"10.1111\/j.1476-5381.1996.tb15588.x"},{"key":"23","unstructured":"27) Genovese A, Gross SS, Sakuma I, Levi R. Adenosine promotes histamine H<sub>1<\/sub>-mediated negative chronotropic and inotropic effects on human atrial myocardium. J Pharmacol Exp Ther. 1988;247:844-849."},{"key":"24","doi-asserted-by":"crossref","unstructured":"30) Kurtz A, Wagner C. Cellular control of renin secretion. J Exp Biol. 1999;202:219-225.","DOI":"10.1242\/jeb.202.3.219"},{"key":"25","unstructured":"31) Fujino T, Yuhki K, Hara A, Hasebe N, Kikuchi K, Ushikubi F. Role of prostanoids in renovascular hypertension. J Pharmacol Sci. 2003;91 Suppl 1:257P."},{"key":"26","doi-asserted-by":"crossref","unstructured":"32) Bunting S, Moncada S, Vane JR. The prostacyclin-thromboxane A<sub>2<\/sub> balance pathophysiological and therapeutic implications. Br Med Bull. 1983;39:271-276.","DOI":"10.1093\/oxfordjournals.bmb.a071832"},{"key":"27","doi-asserted-by":"publisher","unstructured":"33) Ma H, Hara A, Xiao C-Y, et al. Increased bleeding tendency and decreased susceptibility to thromboembolism in mice lacking the prostaglandin E receptor subtype EP<sub>3<\/sub>. Circulation. 2001;104:1176-1180.","DOI":"10.1161\/hc3601.094003"}],"container-title":["Folia Pharmacologica Japonica"],"original-title":["\u5fc3\u8840\u7ba1\u7cfb\u306b\u304a\u3051\u308b\u30d7\u30ed\u30b9\u30bf\u30ce\u30a4\u30c9\u306e\u75c5\u614b\u751f\u7406\u7684\u5f79\u5272"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/122\/5\/122_5_384\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T14:47:45Z","timestamp":1623768465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fpj\/122\/5\/122_5_384\/_article\/-char\/ja\/"}},"subtitle":["&amp;minus;\u53d7\u5bb9\u4f53\u6b20\u640d\u30de\u30a6\u30b9\u3092\u7528\u3044\u305f\u89e3\u6790&amp;minus;"],"short-title":[],"issued":{"date-parts":[[2003]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.1254\/fpj.122.384","relation":{},"ISSN":["0015-5691","1347-8397"],"issn-type":[{"value":"0015-5691","type":"print"},{"value":"1347-8397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003]]}}}